166 related articles for article (PubMed ID: 38227581)
1. Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.
Costa PA; Tse DT; Benedetto P
Oncologist; 2024 Mar; 29(3):263-269. PubMed ID: 38227581
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.
Tse DT; Benedetto PW; Tse BC; Feuer WJ
Am J Ophthalmol; 2022 Aug; 240():239-251. PubMed ID: 35381201
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic Observations of Eyes in Exenterated Orbits After Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Adenoid Cystic Carcinoma of the Lacrimal Gland.
Liao SD; Erickson BP; Kapila N; Dubovy SR; Tse DT
Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3):274-279. PubMed ID: 32890114
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.
Tse DT; Kossler AL; Feuer WJ; Benedetto PW
Ophthalmology; 2013 Jul; 120(7):1313-23. PubMed ID: 23582989
[TBL] [Abstract][Full Text] [Related]
5. Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT; Benedetto P; Dubovy S; Schiffman JC; Feuer WJ
Am J Ophthalmol; 2006 Jan; 141(1):44-53. PubMed ID: 16386975
[TBL] [Abstract][Full Text] [Related]
6. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT
Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic Marker Expression of Resected Lacrimal Gland Adenoid Cystic Carcinoma Tumor Margins After Intra-arterial Chemotherapy and Globe-Sparing Excision.
Shoji MK; Moeyersoms AHM; Wang Q; Gonzalez Hernandez L; Tang VD; Khzam RA; Dubovy SR; Pelaez D; Tse DT
Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):206-211. PubMed ID: 37972978
[TBL] [Abstract][Full Text] [Related]
8. Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy.
Yu MD; Men CJ; Do H; Colevas AD; Lin JH; Egbert PR; Tse DT; Kossler AL
Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e44-e47. PubMed ID: 34798653
[TBL] [Abstract][Full Text] [Related]
9. Targeted Neoadjuvant Intra-arterial Chemotherapy in Lacrimal Gland Adenoid Cystic Carcinoma: A Histological Correlation Using Apoptotic Tumor Markers.
Maniar A; Saqi A; Troob SH; Belinsky I; Charles NC; Gobin YP; Marr BP
Ophthalmic Plast Reconstr Surg; 2022 Jan-Feb 01; 38(1):e28-e33. PubMed ID: 34652309
[TBL] [Abstract][Full Text] [Related]
10. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
[TBL] [Abstract][Full Text] [Related]
11. Pediatric adenoid cystic carcinoma of the lacrimal gland treated with intra-arterial cytoreductive chemotherapy.
Eneh A; Parsa K; Wright KW; Strube YN
J AAPOS; 2015 Jun; 19(3):272-4. PubMed ID: 25890838
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland.
Doddapaneni R; Tao W; Naranjo A; Nikpoor N; Tse DT; Pelaez D
Oncotarget; 2019 Jan; 10(4):480-493. PubMed ID: 30728899
[TBL] [Abstract][Full Text] [Related]
13. Adenoid cystic carcinoma of the lacrimal gland in a 14-year-old male.
Falcone MM; Tran KD; Tavakoli M; Ortiz DF; Barredo JC; Lee WW
Orbit; 2017 Dec; 36(6):448-451. PubMed ID: 28738175
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.
Han J; Kim YD; Woo KI; Sobti D
Ophthalmic Plast Reconstr Surg; 2018; 34(1):74-78. PubMed ID: 28221296
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant intra-arterial chemotherapy in patients with primary lacrimal adenoid cystic carcinoma.
Jang SY; Kim DJ; Kim CY; Wu CZ; Yoon JS; Lee SY
Cancer Imaging; 2014 Apr; 14(1):19. PubMed ID: 25609190
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma.
Zhang M; Fathy C; Breazzano MP; Hollar M; Barahimi B
Int Ophthalmol Clin; 2017; 57(1):143-152. PubMed ID: 27898620
[No Abstract] [Full Text] [Related]
17. Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma cells.
Ye Q; Ding SF; Wang ZA; Feng J; Tan WB
Asian Pac J Cancer Prev; 2014; 15(12):4995-5000. PubMed ID: 24998577
[TBL] [Abstract][Full Text] [Related]
18. Does intra-arterial chemotherapy improve survival for lacrimal gland adenoid cystic carcinoma?
Esmaeli B
Ophthalmology; 2014 Jan; 121(1):e7-e8. PubMed ID: 24268857
[No Abstract] [Full Text] [Related]
19. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.
Yang J; Zhou C; Wang Y; Fan X; Jia R
BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological trends in malignant lacrimal gland tumors.
Andreoli MT; Aakalu V; Setabutr P
Otolaryngol Head Neck Surg; 2015 Feb; 152(2):279-83. PubMed ID: 25385802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
